| Gene Symbol | PDGFRA |
| Entrez ID | 5156 |
| Uniprot ID | P16234 |
| Description | platelet-derived growth factor receptor, alpha polypeptide |
| Chromosomal Location | chr4: 54,229,097-54,298,247 |
| Ontology | GO ID | GO Term | Definition | Evidence |
|---|---|---|---|---|
|
BP |
GO:0000165 |
MAPK cascade |
An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell. |
TAS |
|
BP |
GO:0001553 |
luteinization |
The set of processes resulting in differentiation of theca and granulosa cells into luteal cells and in the formation of a corpus luteum after ovulation. |
ISS |
|
BP |
GO:0001775 |
cell activation |
A change in the morphology or behavior of a cell resulting from exposure to an activating factor such as a cellular or soluble ligand. |
TAS |
|
BP |
GO:0007204 |
positive regulation of cytosolic calcium ion concentration |
Any process that increases the concentration of calcium ions in the cytosol. |
IMP |
|
BP |
GO:0008284 |
positive regulation of cell proliferation |
Any process that activates or increases the rate or extent of cell proliferation. |
IMP |
|
BP |
GO:0010544 |
negative regulation of platelet activation |
Any process that decreases the rate or frequency of platelet activation. Platelet activation is a series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. |
IDA |
|
BP |
GO:0010863 |
positive regulation of phospholipase C activity |
Any process that increases the rate of phospholipase C activity. |
IMP |
|
BP |
GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling |
Any process that modulates the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade. |
TAS |
|
BP |
GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling |
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade. |
TAS |
|
BP |
GO:0016032 |
viral process |
A multi-organism process in which a virus is a participant. The other participant is the host. Includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. In some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, 'complete' its life cycle. |
IEA |
|
BP |
GO:0018108 |
peptidyl-tyrosine phosphorylation |
The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine. |
IDA |
|
BP |
GO:0030335 |
positive regulation of cell migration |
Any process that activates or increases the frequency, rate or extent of cell migration. |
IDA|IMP |
|
BP |
GO:0034614 |
cellular response to reactive oxygen species |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a reactive oxygen species stimulus. Reactive oxygen species include singlet oxygen, superoxide, and oxygen free radicals. |
IDA |
|
BP |
GO:0035790 |
platelet-derived growth factor receptor-alpha signaling pathway |
A series of molecular signals initiated by the binding of a ligand to an alpha-type platelet-derived growth factor receptor (PDGFalpha) on the surface of a signal-receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription. |
IMP |
|
BP |
GO:0038091 |
positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway |
A series of molecular signals initiated by the binding of a vascular endothelial growth factor (VEGF) to a platelet-derived growth factor receptor (PDGFR) on the surface of a cell, which activates or increases the frequency, rate or extent of cell proliferation. |
IDA |
|
BP |
GO:0042060 |
wound healing |
The series of events that restore integrity to a damaged tissue, following an injury. |
ISS |
|
BP |
GO:0043547 |
positive regulation of GTPase activity |
Any process that activates or increases the activity of a GTPase. |
IEA |
|
BP |
GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity |
Any process that activates or increases the frequency, rate or extent of phosphatidylinositol 3-kinase activity. |
IMP |
|
BP |
GO:0045740 |
positive regulation of DNA replication |
Any process that activates or increases the frequency, rate or extent of DNA replication. |
IDA |
|
BP |
GO:0046777 |
protein autophosphorylation |
The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation). |
IDA |
|
BP |
GO:0046854 |
phosphatidylinositol phosphorylation |
The process of introducing one or more phosphate groups into a phosphatidylinositol, any glycerophosphoinositol having one phosphatidyl group esterified to one of the hydroxy groups of inositol. |
IEA |
|
BP |
GO:0048008 |
platelet-derived growth factor receptor signaling pathway |
The series of molecular signals generated as a consequence of a platelet-derived growth factor receptor binding to one of its physiological ligands. |
IDA |
|
BP |
GO:0048015 |
phosphatidylinositol-mediated signaling |
A series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives. |
IMP|TAS |
|
BP |
GO:0048146 |
positive regulation of fibroblast proliferation |
Any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells. |
IDA |
|
BP |
GO:0048557 |
embryonic digestive tract morphogenesis |
The process in which the anatomical structures of the digestive tract are generated and organized during embryonic development. The digestive tract is the anatomical structure through which food passes and is processed. |
ISS |
|
BP |
GO:0048701 |
embryonic cranial skeleton morphogenesis |
The process in which the anatomical structures of the cranial skeleton are generated and organized during the embryonic phase. |
ISS |
|
BP |
GO:0048704 |
embryonic skeletal system morphogenesis |
The process in which the anatomical structures of the skeleton are generated and organized during the embryonic phase. |
ISS |
|
BP |
GO:0050920 |
regulation of chemotaxis |
Any process that modulates the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient. |
IMP |
|
BP |
GO:0055003 |
cardiac myofibril assembly |
The process whose specific outcome is the progression of the cardiac myofibril over time, from its formation to the mature structure. A cardiac myofibril is a myofibril specific to cardiac muscle cells. |
ISS |
|
BP |
GO:0060326 |
cell chemotaxis |
The directed movement of a motile cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis). |
IMP |
|
BP |
GO:0061298 |
retina vasculature development in camera-type eye |
The process whose specific outcome is the progression of the vasculature of the retina over time, from its formation to the mature structure. |
ISS |
|
BP |
GO:0070374 |
positive regulation of ERK1 and ERK2 cascade |
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. |
IMP |
|
BP |
GO:0070527 |
platelet aggregation |
The adhesion of one platelet to one or more other platelets via adhesion molecules. |
IMP |
|
BP |
GO:0072277 |
metanephric glomerular capillary formation |
The process that gives rise to a metanephric glomerular capillary. This process pertains to the initial formation of a structure from unspecified parts. |
ISS |
|
BP |
GO:2000249 |
regulation of actin cytoskeleton reorganization |
Any process that modulates the frequency, rate or extent of actin cytoskeleton reorganization. |
TAS |
|
BP |
GO:2000739 |
regulation of mesenchymal stem cell differentiation |
Any process that modulates the frequency, rate or extent of mesenchymal stem cell differentiation. |
IMP |
|
CC |
GO:0005634 |
nucleus |
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
ISS |
|
CC |
GO:0005737 |
cytoplasm |
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
ISS |
|
CC |
GO:0005886 |
plasma membrane |
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
TAS |
|
CC |
GO:0005887 |
integral component of plasma membrane |
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
IDA |
|
CC |
GO:0016020 |
membrane |
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
IDA |
|
CC |
GO:0031226 |
intrinsic component of plasma membrane |
The component of the plasma membrane consisting of the gene products and protein complexes having either part of their peptide sequence embedded in the hydrophobic region of the membrane or some other covalently attached group such as a GPI anchor that is similarly embedded in the membrane. |
IDA |
|
CC |
GO:0043234 |
protein complex |
A stable macromolecular complex composed (only) of two or more polypeptide subunits along with any covalently attached molecules (such as lipid anchors or oligosaccharide) or non-protein prosthetic groups (such as nucleotides or metal ions). Prosthetic group in this context refers to a tightly bound cofactor. The component polypeptide subunits may be identical. |
IDA |
|
MF |
GO:0004672 |
protein kinase activity |
Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP. |
IDA |
|
MF |
GO:0004714 |
transmembrane receptor protein tyrosine kinase activity |
Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP + a protein-L-tyrosine = ADP + a protein-L-tyrosine phosphate. |
IDA |
|
MF |
GO:0005018 |
platelet-derived growth factor alpha-receptor activity |
Combining with platelet-derived growth factor isoform PDGF-AA, PDGF-BB or PDGF-AB to initiate a change in cell activity. |
IDA|IMP |
|
MF |
GO:0005021 |
vascular endothelial growth factor-activated receptor activity |
Combining with a vascular endothelial growth factor (VEGF) and transmitting the signal across the plasma membrane to initiate a change in cell activity. |
IDA |
|
MF |
GO:0005088 |
Ras guanyl-nucleotide exchange factor activity |
Stimulates the exchange of guanyl nucleotides associated with a GTPase of the Ras superfamily. Under normal cellular physiological conditions, the concentration of GTP is higher than that of GDP, favoring the replacement of GDP by GTP in association with the GTPase. |
TAS |
|
MF |
GO:0005161 |
platelet-derived growth factor receptor binding |
Interacting selectively and non-covalently with the platelet-derived growth factor receptor. |
IPI |
|
MF |
GO:0005515 |
protein binding |
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
IPI |
|
MF |
GO:0005524 |
ATP binding |
Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
IEA |
|
MF |
GO:0038085 |
vascular endothelial growth factor binding |
Interacting selectively and non-covalently with a vascular endothelial growth factor. |
IPI |
|
MF |
GO:0042803 |
protein homodimerization activity |
Interacting selectively and non-covalently with an identical protein to form a homodimer. |
IDA |
|
MF |
GO:0046934 |
phosphatidylinositol-4,5-bisphosphate 3-kinase activity |
Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + ATP = a 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + ADP + 2 H(+). |
TAS |
|
MF |
GO:0048407 |
platelet-derived growth factor binding |
Interacting selectively and non-covalently with platelet-derived growth factor. |
IDA|IPI |
| Domain ID | Description |
|---|---|
|
IPR000719 |
Protein kinase domain |
|
IPR001245 |
Serine-threonine/tyrosine-protein kinase, catalytic domain |
|
IPR001824 |
Tyrosine-protein kinase, receptor class III, conserved site |
|
IPR003598 |
Immunoglobulin subtype 2 |
|
IPR003599 |
Immunoglobulin subtype |
|
IPR007110 |
Immunoglobulin-like domain |
|
IPR008266 |
Tyrosine-protein kinase, active site |
|
IPR011009 |
Protein kinase-like domain |
|
IPR013098 |
Immunoglobulin I-set |
|
IPR013783 |
Immunoglobulin-like fold |
|
IPR016243 |
Tyrosine-protein kinase, CSF-1/PDGF receptor family |
|
IPR017441 |
Protein kinase, ATP binding site |
|
IPR020635 |
Tyrosine-protein kinase, catalytic domain |
|
IPR027290 |
Platelet-derived growth factor receptor alpha |
| Pathway ID | Pathway Term | Pathway Source |
|---|---|---|
|
hsa01521 |
EGFR tyrosine kinase inhibitor resistance |
KEGG |
|
hsa04010 |
MAPK signaling pathway |
KEGG |
|
hsa04014 |
Ras signaling pathway |
KEGG |
|
hsa04015 |
Rap1 signaling pathway |
KEGG |
|
hsa04020 |
Calcium signaling pathway |
KEGG |
|
hsa04060 |
Cytokine-cytokine receptor interaction |
KEGG |
|
hsa04072 |
Phospholipase D signaling pathway |
KEGG |
|
hsa04144 |
Endocytosis |
KEGG |
|
hsa04151 |
PI3K-Akt signaling pathway |
KEGG |
|
hsa04510 |
Focal adhesion |
KEGG |
|
hsa04540 |
Gap junction |
KEGG |
|
hsa04810 |
Regulation of actin cytoskeleton |
KEGG |
|
hsa05166 |
HTLV-I infection |
KEGG |
|
hsa05200 |
Pathways in cancer |
KEGG |
|
hsa05206 |
MicroRNAs in cancer |
KEGG |
|
hsa05214 |
Glioma |
KEGG |
|
hsa05215 |
Prostate cancer |
KEGG |
|
hsa05218 |
Melanoma |
KEGG |
|
hsa05230 |
Central carbon metabolism in cancer |
KEGG |
|
hsa05231 |
Choline metabolism in cancer |
KEGG |
|
WP3640 |
Imatinib and Chronic Myeloid Leukemia |
WikiPathways |
|
WP2328 |
Allograft Rejection |
WikiPathways |
|
WP306 |
Focal Adhesion |
WikiPathways |
|
WP3611 |
Photodynamic therapy-induced AP-1 survival signaling. |
WikiPathways |
|
WP51 |
Regulation of Actin Cytoskeleton |
WikiPathways |
|
WP3931 |
ESC Pluripotency Pathways |
WikiPathways |
|
WP1539 |
Angiogenesis |
WikiPathways |
|
WP322 |
Osteoblast Signaling |
WikiPathways |
|
WP2261 |
Signaling Pathways in Glioblastoma |
WikiPathways |
|
WP2406 |
Cardiac Progenitor Differentiation |
WikiPathways |
|
WP3932 |
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway |
WikiPathways |
|
h_cblPathway |
CBL mediated ligand-induced downregulation of EGF receptors |
BioCarta |
|
h_erkPathway |
Erk1/Erk2 Mapk Signaling pathway |
BioCarta |
|
h_pdgfPathway |
PDGF Signaling Pathway |
BioCarta |
|
h_edg1Pathway |
Phospholipids as signalling intermediaries |
BioCarta |
|
h_rac1Pathway |
Rac 1 cell motility signaling pathway |
BioCarta |
|
h_cdc42racPathway |
Role of PI3K subunit p85 in regulation of Actin Organization and Cell Migration |
BioCarta |
| UMLS CUI | UMLS Term |
|---|---|
|
C0008925 |
Cleft Palate |
|
C0015927 |
Fetal Death |
|
C0024115 |
Lung Diseases |
|
C0025149 |
Medulloblastoma |
|
C0035238 |
Congenital Abnormality Of Respiratory System |
|
C0080178 |
Spina Bifida |
|
C0206637 |
Chondrosarcoma, Mesenchymal |
|
C0238198 |
Gastrointestinal Stromal Tumors |
|
C0376634 |
Craniofacial Abnormalities |
|
C1540912 |
Hypereosinophilic Syndrome |
| Tissue | Cell Type |
|---|---|
|
cerebral cortex |
endothelial cells |
| Pubmed ID | Author | Year | Title |
|---|---|---|---|
|
22617121 |
Ouandaogo et al. |
2012 |
Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation |
|
22951915 |
Haozi et al. |
2012 |
Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome |
|
23824412 |
Piltonen et al. |
2013 |
Mesenchymal Stem/Progenitors and Other Endometrial Cell Types From Women With Polycystic Ovary Syndrome (PCOS) Display Inflammatory and Oncogenic Potential |
| Gene Symbol | Entrez ID | Uniprot ID | Score |
|---|---|---|---|
|
PLCG2 |
5336 |
P16885 |
0.00 |
|
SH3GL1 |
6455 |
Q99961 |
0.00 |
|
SH3GL3 |
6457 |
Q99963 |
0.00 |
|
SRC |
6714 |
P12931 |
0.00 |
|
RNF41 |
10193 |
Q9H4P4 |
0.00 |
|
WWP1 |
11059 |
Q9H0M0 |
0.00 |
|
SH3GLB1 |
51100 |
Q9Y371 |
0.00 |
|
SH3GLB2 |
56904 |
Q9NR46 |
0.00 |
|
SMURF2 |
64750 |
Q9HAU4 |
0.00 |
|
STAT5A |
6776 |
P42229 |
0.52 |
|
STAT5B |
6777 |
P51692 |
0.52 |
|
H3F3A; H3F3B |
3020 |
P84243 |
0.63 |
|
KIT |
3815 |
P10721 |
0.63 |
|
RNPS1 |
10921 |
Q15287 |
0.63 |
|
ULBP2 |
80328 |
Q9BZM5 |
0.63 |
|
CCDC155 |
147872 |
Q8N6L0 |
0.63 |
|
STAT1 |
6772 |
P42224 |
0.65 |
|
SRPK1 |
6732 |
Q96SB4 |
0.70 |
|
CLU |
1191 |
P10909 |
0.72 |
|
DSG2 |
1829 |
Q14126 |
0.72 |
|
MYO1C |
4641 |
O00159 |
0.72 |
|
NRDC |
4898 |
O43847 |
0.72 |
|
TFRC |
7037 |
P02786 |
0.72 |
|
TNK1 |
8711 |
Q13470 |
0.72 |
|
FARP1 |
10160 |
Q9Y4F1 |
0.72 |
|
FLOT1 |
10211 |
O75955 |
0.72 |
|
SCFD1 |
23256 |
Q8WVM8 |
0.72 |
|
PPIL2 |
23759 |
Q13356 |
0.72 |
|
PACSIN3 |
29763 |
Q9UKS6 |
0.72 |
|
WDR74 |
54663 |
Q6RFH5 |
0.72 |
|
PRKRIP1 |
79706 |
Q9H875 |
0.72 |
|
RAB11FIP1 |
80223 |
Q6WKZ4 |
0.72 |
|
MAK16 |
84549 |
Q9BXY0 |
0.72 |
|
PHLDB2 |
90102 |
Q86SQ0 |
0.72 |
|
ITGB3 |
3690 |
P05106 |
0.74 |
|
GRB2 |
2885 |
P62993 |
0.82 |
|
PDGFRA |
5156 |
P16234 |
0.89 |
|
PLCG1 |
5335 |
P19174 |
0.89 |
|
CRK |
1398 |
P46108 |
0.90 |
|
PDGFA |
5154 |
P04085 |
0.90 |
|
PDGFRB |
5159 |
P09619 |
0.90 |
|
FGF1 |
2246 |
P05230 |
0.00 |
|
FGF2 |
2247 |
P09038 |
0.00 |
|
FGF3 |
2248 |
P11487 |
0.00 |
|
FGF5 |
2250 |
P12034 |
0.00 |
|
FGF6 |
2251 |
P10767 |
0.00 |
|
FGF7 |
2252 |
P21781 |
0.00 |
|
FGF8 |
2253 |
P55075 |
0.00 |
|
FGF12 |
2257 |
P61328 |
0.00 |
|
FGF13 |
2258 |
Q92913 |
0.00 |
|
FIGF |
2277 |
O43915 |
0.00 |
|
HGF |
3082 |
P14210 |
0.00 |
|
IGF1 |
3479 |
P05019 |
0.00 |
|
KRAS |
3845 |
P01116 |
0.00 |
|
NEDD4 |
4734 |
P46934 |
0.00 |
|
EPN2 |
22905 |
O95208 |
0.00 |
|
NEDD4L |
23327 |
Q96PU5 |
0.00 |
|
EPN1 |
29924 |
Q9Y6I3 |
0.00 |
|
ITCH |
83737 |
Q96J02 |
0.00 |
|
JAK1 |
3716 |
P23458 |
0.52 |
|
FBXO25 |
26260 |
Q8TCJ0 |
0.52 |
|
SHF |
90525 |
Q7M4L6 |
0.52 |
|
GRB14 |
2888 |
Q14449 |
0.55 |
|
ITGAV |
3685 |
P06756 |
0.55 |
|
SHB |
6461 |
Q15464 |
0.55 |
|
NTRK1 |
4914 |
P04629 |
0.63 |
|
PTEN |
5728 |
P60484 |
0.63 |
|
TGFBR2 |
7048 |
P37173 |
0.63 |
|
VEGFA |
7422 |
P15692 |
0.63 |
|
PTPN11 |
5781 |
Q06124 |
0.65 |
|
STAT3 |
6774 |
P40763 |
0.65 |
|
PKM |
5315 |
P14618 |
0.68 |
|
THOC5 |
8563 |
Q13769 |
0.72 |
|
SNX2 |
6643 |
O60749 |
0.74 |
|
SNX6 |
58533 |
Q9UNH7 |
0.74 |
|
CAV3 |
859 |
P56539 |
0.75 |
|
PIK3R1 |
5295 |
P27986 |
0.78 |
|
CBL |
867 |
P22681 |
0.79 |
|
SNX4 |
8723 |
O95219 |
0.83 |
|
CRKL |
1399 |
P46109 |
0.87 |
|
CAV1 |
857 |
Q03135 |
0.88 |
|
EGFR |
1956 |
P00533 |
0.88 |
|
SLC9A3R1 |
9368 |
O14745 |
0.89 |
|
PDGFB |
5155 |
P01127 |
0.90 |
|
PDGFC |
56034 |
Q9NRA1 |
0.90 |